Letter: A better way to spend Ineos’ Oxford gift

  22 January 2021

After reading “Ratcliffe’s Ineos makes £100m Oxford donation to tackle antibiotic resistance” (Report, January 19), my first thought was if half as much money was invested in preventive practice in human primary care and animal welfare, antimicrobial resistance (AMR) would be substantially de-fuelled, giving Ineos, Oxford university and others a much longer runway to get next-generation cures developed, trialled, peer reviewed and commercialised.

 

Further reading: Financial Times
Author(s): Giovanna Forte
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition





Technology Database

Display your AMR Technology, Product and Service

 

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

 

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!